Aixiao Xu

703 total citations
15 papers, 418 citations indexed

About

Aixiao Xu is a scholar working on Molecular Biology, Hematology and Neurology. According to data from OpenAlex, Aixiao Xu has authored 15 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Neurology. Recurrent topics in Aixiao Xu's work include Retinoids in leukemia and cellular processes (5 papers), Acute Myeloid Leukemia Research (4 papers) and RNA Interference and Gene Delivery (4 papers). Aixiao Xu is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Acute Myeloid Leukemia Research (4 papers) and RNA Interference and Gene Delivery (4 papers). Aixiao Xu collaborates with scholars based in China and Kazakhstan. Aixiao Xu's co-authors include Jingwei Shao, Ruirui Zhao, Zhichun Shen, Guirong Zheng, Qiaojun He, Xuejing Shao, Ji Cao, Xian Chen, Lulu Fan and Hong Zhu and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Journal of Agricultural and Food Chemistry.

In The Last Decade

Aixiao Xu

14 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aixiao Xu China	10	264	110	86	54	52	15	418
Pasupathi Sundaramoorthy United States	13	209 0.8×	139 1.3×	105 1.2×	25 0.5×	42 0.8×	17	445
Zhirui Zhang China	11	138 0.5×	53 0.5×	57 0.7×	27 0.5×	58 1.1×	28	342
Xiuhua Wu China	10	230 0.9×	52 0.5×	39 0.5×	62 1.1×	35 0.7×	11	442
Suraj K. George United States	14	204 0.8×	90 0.8×	83 1.0×	28 0.5×	63 1.2×	23	518
Kuan-Boone Tan Singapore	8	218 0.8×	117 1.1×	79 0.9×	12 0.2×	37 0.7×	10	397
Yihong He China	12	177 0.7×	120 1.1×	104 1.2×	26 0.5×	26 0.5×	20	420
Qie Guo China	13	209 0.8×	89 0.8×	60 0.7×	15 0.3×	77 1.5×	41	497
Zhenglai Hua China	10	186 0.7×	63 0.6×	66 0.8×	21 0.4×	86 1.7×	12	397
Khan Asifullah China	6	193 0.7×	191 1.7×	123 1.4×	13 0.2×	23 0.4×	7	438
Yixin Wu China	16	312 1.2×	58 0.5×	63 0.7×	16 0.3×	132 2.5×	36	551

Countries citing papers authored by Aixiao Xu

Since Specialization

Citations

This map shows the geographic impact of Aixiao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixiao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixiao Xu more than expected).

Fields of papers citing papers by Aixiao Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aixiao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixiao Xu. The network helps show where Aixiao Xu may publish in the future.

Co-authorship network of co-authors of Aixiao Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Aixiao Xu. A scholar is included among the top collaborators of Aixiao Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aixiao Xu. Aixiao Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Xiang, Senfeng, Pengfei Chen, Haoyang Cai, et al.. (2025). Disruption of the KLHL37–N-Myc complex restores N-Myc degradation and arrests neuroblastoma growth in mouse models. Journal of Clinical Investigation. 135(14).

Xu, Aixiao, Yunpeng Huang, Bing Wu, et al.. (2025). Phase separation-based screening identifies arsenic trioxide as the N-Myc-DNA interaction inhibitor for neuroblastoma therapy. Cancer Letters. 612. 217449–217449. 2 indexed citations

Shao, Xuejing, Wei Wang, Aixiao Xu, et al.. (2024). Palmitoyltransferase ZDHHC3 is essential for the oncogenic activity of PML/RARα in acute promyelocytic leukemia. Acta Pharmacologica Sinica. 46(2). 462–473. 3 indexed citations

Xiang, Senfeng, Yilong Wang, Zhonghai Guan, et al.. (2023). AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells. Acta Pharmaceutica Sinica B. 13(4). 1522–1536. 5 indexed citations

Shao, Xuejing, Aixiao Xu, Wenxin Du, et al.. (2023). Palmitoyltransferase ZDHHC21 regulates oxidative phosphorylation to induce differentiation block and stemness in AML. Blood. 142(4). 365–381. 28 indexed citations

Shao, Xuejing, Yingqian Chen, Aixiao Xu, et al.. (2022). Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL. Cell Death and Differentiation. 29(8). 1654–1668. 18 indexed citations

Wang, Wei, Yingqian Chen, Aixiao Xu, et al.. (2020). Protein phase separation: A novel therapy for cancer?. British Journal of Pharmacology. 177(22). 5008–5030. 18 indexed citations

Du, Wenxin, Aixiao Xu, Ji Cao, et al.. (2020). The role of autophagy in targeted therapy for acute myeloid leukemia. Autophagy. 17(10). 2665–2679. 77 indexed citations

Shao, Xuejing, Senfeng Xiang, Huarui Fu, et al.. (2019). CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells. Pharmacological Research. 151. 104545–104545. 14 indexed citations

10.

Xu, Aixiao, Ji Cao, Hong Zhu, et al.. (2019). Post-translational modification of retinoic acid receptor alpha and its roles in tumor cell differentiation. Biochemical Pharmacology. 171. 113696–113696. 12 indexed citations

11.

Fan, Lulu, Bingchen Zhang, Aixiao Xu, et al.. (2018). Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy. Molecular Pharmaceutics. 15(6). 2466–2478. 100 indexed citations

12.

Shao, Jingwei, Guirong Zheng, Hongning Chen, et al.. (2017). Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway. Oncotarget. 8(45). 78351–78364. 9 indexed citations

13.

Zheng, Guirong, Ruirui Zhao, Aixiao Xu, et al.. (2017). Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy. European Journal of Pharmaceutical Sciences. 111. 492–502. 78 indexed citations

14.

Zheng, Guirong, Yiling Shen, Ruirui Zhao, et al.. (2017). Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells. Journal of Agricultural and Food Chemistry. 65(32). 6904–6911. 42 indexed citations

15.

Zheng, Guirong, Zhichun Shen, Aixiao Xu, et al.. (2017). Synergistic Chemopreventive and Therapeutic Effects of Co-drug UA-Met: Implication in Tumor Metastasis. Journal of Agricultural and Food Chemistry. 65(50). 10973–10983. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact